Recent appointments include Martin Stumpe named as Danaher’s Chief Technology and AI Officer, and Marjorie Green joining NeoGenomics’ board with a strong oncology development background. Qiagen’s board sees Stephen Rusckowski appointed as chairman, continuing corporate restructuring. On financing, Forsight Robotics secured $125 million in Series B funding for its robotic cataract surgery platform. Biopharma market funding also sees ongoing activity, with several companies raising capital to advance innovative pipelines and technologies, reflecting sustained investor interest in life sciences.